Nytt steg närmare marknaden för Sobis giktläkemedel

Läkemedelsutvecklaren Sobi har inlett en stegvis ansökan om marknadsgodkännande i USA för bolagets nya giktläkemedel Sel-212.

Individual DNA passport could result in fewer drug side effects

You may be required to show a DNA passport when you pick up medicines at the pharmacy in the future. According to a new study, patients might suffer 30% fewer s...

Drug development creates new challenges for regulators

Smartcella värvar från Millipore Sigma

Biotech- och medtechbolaget Smartcella har utsett Nina Bauer till ny Chief Business Officer och Head of Smartwise.

An increasing number of people are falling ill with TBE – “Much more research is needed”

Tick-borne meningitis, or TBE, is an increasingly common disease in Sweden. Currently, there is a vaccine against the disease but no drugs. Researcher Anna Över...

Mercodia AB

Hon blir ny medicinsk chef på Synact Pharma

Synact Pharma, som bland annat utvecklar behandlingar för reumatiska sjukdomar, har utsett Kirsten Harting till ny Chief Medical Officer.

Claims of life science companies fleeing abroad is a myth according to survey

The claim that life science companies are moving abroad is exaggerated. In fact, only a tiny percentage is leaving the country, according to a survey.

Ännu ett Alzheimerläkemedel godkänt – lecanemab får konkurrens

Eli Lillys läkemedel donanemab mot Alzheimers godkändes på tisdagen av den amerikanska läkemedelsmyndigheten FDA. Det är det andra godkända bromsläkemedlet mot ...

Clinigen Clinical Supplies Management GmbH

ZEISS Connected Quality: One metrology hub

The new product family ZEISS CONNECTED QUALITY is the solution for quick and secure data exchange, quality management and efficient system monitoring.

Hon är KI-bolaget Neobiomics nya vd

Neobiomics, som utvecklar produkter inom neonatalområdet, har utsett Emma Höglund till ny vd.

Affibody AB

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

Your solution for right part positioning

ZEISS OmniFix CT - right part positioning solution to get meaningful measuring results for all part sizes.

Marie Gårdmark: New incentives for orphan products on its way

"Let’s hope that the learnings from development of new therapies for rare diseases will spill over to more common conditions, orphan products paving the wave fo...

QPS Netherlands B.V

Save the dates: ZEISS Quality Innovation Summit, October 22-24

Embark on a journey to the future of metrology.

RegSmart Life Science AB

Truly Labs AB

Optimize Courier SUPPLIERS (DISTRIBUTORS)

CTC Clinical Trial Consultants AB

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.

Discover Precision: Join ZEISS at the Control Fair in Stuttgart

May 6-9, 2025 in Stuttgart. Hall 9, Booth 9309.